Early identification of pituitary dysfunction in congenital nasal pyriform aperture stenosis: recommendations based

Suet Ching Chen1, Helen McDevitt, W Andrew Clement

  • 1Department of Paediatric Endocrinology, Royal Hospital for Sick Children, Glasgow, UK.

Insights

Congenital nasal pyriform aperture stenosis (CNPAS) patients need early pituitary evaluation. Monitoring growth for one year can predict pituitary dysfunction, minimizing surgical risks.

Area of Science:

  • Pediatric Endocrinology
  • Otolaryngology
  • Medical Genetics

Background:

  • Congenital nasal pyriform aperture stenosis (CNPAS) is linked to midline abnormalities and upper airway obstruction.
  • Previous studies indicate a high incidence of pituitary dysfunction in CNPAS patients (40%).
  • Current diagnostic and follow-up protocols for pituitary insufficiency in CNPAS are inconsistent.

Purpose of the Study:

  • To establish guidelines for early identification of pituitary insufficiency in CNPAS patients.
  • To minimize surgical risks associated with undiagnosed pituitary dysfunction.
  • To develop a patient stratification strategy for appropriate follow-up.

Main Methods:

  • Retrospective review of 20 CNPAS patients treated between 2000 and 2014.
  • Analysis of diagnostic approaches to pituitary axis evaluation.
  • Correlation of clinical findings with pituitary dysfunction incidence.

Main Results:

  • Pituitary dysfunction was identified in 15% of patients, often diagnosed later in childhood.
  • Hypoglycemia and conjugated hyperbilirubinemia were significant predictors of pituitary dysfunction.
  • Height SDS at 1 year effectively identified patients with growth hormone deficiency.

Conclusions:

  • Recommend MRI and baseline endocrine tests for all CNPAS patients at diagnosis.
  • Suggest growth monitoring for at least one year post-diagnosis.
  • Low or falling height SDS at one year is a reliable indicator of potential pituitary dysfunction.
Abstract